1. Mangano DT. Perioperative cardiac morbidity—epidemiology, costs, problems, and solutions (editorial). West Med J 1994; 161: 87–89.
2. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CRH. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 744–748.
3. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201–1205.
4. Apple FS, Adams JE, Wu AHB, Jaffe AS. Report on survey of analytical and clinical characteristics of commercial cardiac troponin assays. In: Markers in Cardiology; Current and Future Clinical Applications. Adams JE, Apple F, Jaffe A, Wu A, eds. Armonk, NY: Futura, 2000, pp. 31–34.
5. Tate JR, Heathcote D, Rayfield J, Hickman PE. The lack of standardization of cardiac troponin I assay systems. Clin Chim Acta 1999; 284: 141–149.